Klaus Martin

Klaus Martin

Company: Topas Therapeutics

Job title: Chief Executive Officer


A nanoparticle platform for multiple immune tolerance therapies 3:00 pm

Broad therapeutic potential of our proprietary Topas Particle Conjugates delivering peptide antigens to special liver cells Diverse mechanism-of-action through different immune pathways to rebalance the immune system Pemphigus vulgaris and Celiac disease as strong clinical modelsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.